ConductScience.org, home

Paper7749136

Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer.

Iwase H and 9 others. Breast Cancer Res Treat, 1995. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer. Papers, record 7749136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7749136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer.
PubMed
Journal
Breast Cancer Res Treat
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2026-10-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iwase HH
2Kobayashi SS
3Itoh YY
4Fukuoka HH
5Kuzushima TT
6Iwata HH
7Yamashita TT
8Naitoh AA
9Itoh KK
10Masaoka AA

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Breast NeoplasmsMajor topic
Carcinoembryonic Antigen
Glycoproteins
Humans
Mucin-1
Recurrence

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1707698Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer.Am J Surg1978https://conductscience.org/library/papers/707698PubMed
22730960Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases.Breast Cancer Res Treat1989https://conductscience.org/library/papers/2730960PubMed
32039707The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.Br J Cancer1991https://conductscience.org/library/papers/2039707PubMed
42779026The clinical value of serum CA15-3 assay postoperatively in breast cancer patients.Jpn J Surg1989https://conductscience.org/library/papers/2779026PubMed
56205927Monoclonal antibody reactive with the sialyl-sugar residue of a high molecular weight glycoprotein in sera of cancer patients.Gan1984https://conductscience.org/library/papers/6205927PubMed
63341450Immunocytochemical distribution of a breast carcinoma associated glycoprotein identified by monoclonal antibodies.Am J Pathol1988https://conductscience.org/library/papers/3341450PubMed
78440454[Follow-up of tumor markers in evaluating the effectiveness of chemo- or hormone therapy in metastatic breast cancer].Geburtshilfe Frauenheilkd1993https://conductscience.org/library/papers/8440454PubMed
81777973CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer.Clin Chim Acta1991https://conductscience.org/library/papers/1777973PubMed
92790682Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease.Cancer1989https://conductscience.org/library/papers/2790682PubMed
101995353The use of CA15.3 as a serum tumour marker in breast carcinoma.Eur J Surg Oncol1991https://conductscience.org/library/papers/1995353PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42831963Preoperative CA15-3 as a predictor of axillary lymph node metastasis and prognosis in women with breast cancer: a GRADE-assessed systematic review and meta-analysis.Breast Cancer2026https://conductscience.org/library/papers/42831963PubMed
40098805Clinical Value of Serum sTim-3, CEA, CA15-3 for Postoperative Recurrence of Breast Cancer.Cancer Manag Res2025https://conductscience.org/library/papers/40098805PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084NCBI Gene
MUC14582PubTator's text mininghttps://conductscience.org/library/genes/4582NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7749136

GET https://conductscience.org/api/papers/v1/7749136/authors